Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

CVS adds four new board members in deal with Glenview Capital

admin by admin
November 18, 2024
in Stock
0
CVS adds four new board members in deal with Glenview Capital
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

By Sriparna Roy

(Reuters) -CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital’s chief executive Larry Robbins as part of a standstill agreement with the activist investor.

Shares of CVS rose 2% to $54.30 in premarket trading.

The Rhode Island-based company, which has been facing pressure from investors including Glenview, is looking to improve its operations and shareholder value even as it combats with increased medical costs at its health insurance business.

Glenview, which has a 0.95% stake in the company as of Sept. 30, said its agreement with CVS included other confidential provisions. Two other activist shareholders, Third Point and Sachem Capital (NYSE:SACH), also have stakes of 0.13% and 0.28%, respectively, in the company as of Sept. 30.

“While having additional expertise as part of the company/Board is never a bad thing, we don’t think this really changes anything beyond where we think CVS had already started to point the ship,” said Michael Cherny, analyst at Leerink Partners.

CVS had earlier this month named Steve Nelson, a former UnitedHealth (NYSE:UNH) insurance head, to run its Aetna business.

This came a few weeks after the conglomerate replaced Karen Lynch as its CEO with David Joyner, as higher medical costs continued to plague its health insurance unit Aetna, and also executed a strategic review. Glenview had said at the time it supported the resignation of Lynch.

Robbins, who likes to be called a constructivist shareholder, had recently met with executives to push for changes. He did not call for a break up of CVS.

Three other executives from Glenview – Leslie Norwalk, Guy Sansone and Doug Shulman – will join Robbins on the CVS board, bringing the total members to 16.

This post appeared first on investing.com

Previous Post

Earnings call: Acme Corp reports mixed Q1 results, shares details on performance

Next Post

Brazil’s Embraer signs MoU to expand collaboration with Indonesia’s PTDI

admin

admin

Next Post
Brazil’s Embraer signs MoU to expand collaboration with Indonesia’s PTDI

Brazil’s Embraer signs MoU to expand collaboration with Indonesia’s PTDI

Trending News

Raytheon secures $1.3 billion F-35 engine support contract

Raytheon secures $1.3 billion F-35 engine support contract

December 3, 2024
Citi gets more defensive on chip stocks, cuts ratings

Citi gets more defensive on chip stocks, cuts ratings

September 16, 2024
Long AMZN: bullish breakout signals uptrend as $200 support holds, targeting $230 amid black friday optimism

Long AMZN: bullish breakout signals uptrend as $200 support holds, targeting $230 amid black friday optimism

November 20, 2024
Subscribe to Insightful Word


    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025
    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    August 7, 2025
    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    August 7, 2025

    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025

    Latest News

    • Dow futures soar 250 points today: 5 things to know before Wall Street opens
    • Affirm stock price is rising: is it a buy before earnings?
    • Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.